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of Gene-by-Environment Interactions in Human Cells
Casey E. Romanoski,1,* Sangderk Lee,2 Michelle J. Kim,3 Leslie Ingram-Drake,2 Christopher L. Plaisier,4
Roumyana Yordanova,5 Charles Tilford,5 Bo Guan,5 Aiqing He,5 Peter S. Gargalovic,5
Todd G. Kirchgessner,5 Judith A. Berliner,2,6 and Aldons J. Lusis1,3,6,*
Gene by environment (GxE) interactions are clearly important inmany human diseases, but they have proven to be difﬁcult to study on
a molecular level. We report genetic analysis of thousands of transcript abundance traits in human primary endothelial cell (EC) lines in
response to proinﬂammatory oxidized phospholipids implicated in cardiovascular disease. Of the 59 most regulated transcripts, approx-
imately one-third showed evidence of GxE interactions. The interactions resulted primarily from effects of distal-, trans-acting loci, but
a striking example of a local-GxE interaction was also observed for FGD6. Some of the distal interactions were validated by siRNA knock-
down experiments, including a locus involved in the regulation of multiple transcripts involved in the ER stress pathway. Our ﬁndings
add to the understanding of the overall architecture of complex human traits and are consistent with the possibility that GxE interac-
tions are responsible, in part, for the failure of association studies to more fully explain common disease variation.Introduction
During the past few years, great progress has been made in
understanding the overall genetic architecture of complex
traits in human populations and the genetic control of
gene expression.1 Genome-wide association (GWA) stu-
dies, in particular, have revealed hundreds of loci that
contribute to many common diseases as well as other
complex traits. These studies are poorly powered, however,
to detect gene by gene (GxG) and gene by environment
(GxE) interactions,2 which are likely to be important in
common diseases such as heart disease,3 behavioral disor-
ders,4,5 and cancer.6 In particular, such studies are limited
to a small number of phenotypes and loci, and the under-
lying molecular details have generally not been examined.
The importance of such interactions is evident in the
commonly observed context-dependent effects of quanti-
tative trait loci (QTL) in studies of experimental organisms
(reviewed in Mackay et al.5). Thus, when QTL studies are
performed in different environments, it has frequently
been observed that different loci are observed or the
magnitude of the QTL effects differ. Recently, more global
analyses of GxE interactions have been studied with global
expression traits in yeast7,8 and worms.9 Such studies
revealed common GxE interactions in a variety of environ-
mental conditions such as drug treatments, energy sources,
and growth temperatures. Global expression studies of
lymphoblastoid cell responses to radiation also suggested
the importance of GxE interactions in human cells.10
Clearly, an understanding of GxE interactions in human
populations will be important for studying common
disease susceptibility and for inﬂuencing lifestyle decisions
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Atherosclerosis, the primary cause of heart disease, is
a disease in which both genetic and environmental factors
play a major role. Among the important environmental
factors in atherosclerosis are diet, smoking, exercise, and
infectious agents, and there is evidence from candidate
gene studies that some of these interact with genetic
factors.3 Over the past two decades, it has become clear
that atherosclerosis is an inﬂammatory disorder and that
oxidized lipids present in low-density lipoproteins (LDLs)
or dying cells trapped in the vessel wall contribute to this
inﬂammation.11 Oxidized lipids induce the overlying
endothelial cells (ECs) to express adhesion molecules and
cytokines that promote the recruitment of monocytes
and lymphocytes to the vessel wall.12 However, the mech-
anisms underlying the wide responses caused by oxidized
lipids remain poorly understood.
To better understand the mechanisms underlying
vascular inﬂammation, and the nature of genetic varia-
tions contributing to disease susceptibility, we performed
a systems genetics analysis of EC responses to oxidized
phospholipids. We utilized a population of primary early
passage human aortic endothelial cell (HAEC) cultures
from 96 unrelated heart transplant donors. The donors
in this study were anonymous and so ethnicity was
unknown. The cells were treated with the oxidized phos-
pholipid species, oxidized 1-palmitoyl-2-arachidonoyl-sn-
glycero-3-phosphatidylcholine (Ox-PAPC), a component
of oxidized LDL found in atherosclerotic lesions of animal
models and humans.12 Ox-PAPC is known to promote
vascular inﬂammation and robust gene regulation of over
1000 transcripts in this cell type.13 We then performed095, USA; 2Department of Pathology and Laboratory Medicine, Division of
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Figure 1. Experimental Designglobal expression array analyses on our population of
HAECs both with and without Ox-PAPC treatment. In
addition, we typed each of the cultures for approximately
one million common single nucleotide polymorphisms
(SNPs) using high-density SNP arrays. Genome-wide asso-
ciation (GWA) analysis of the data revealed thousands of
loci controlling transcript levels, whichwe term expression
quantitative trait loci (eQTL). Among these were many loci
controlling responses to Ox-PAPC.
One important conclusion to emerge from these results,
relevant to the understanding of genetic architecture
underlying mRNA expression levels, was evidence of GxE
interactions. Gene expression responsiveness trait values
were examined as a function of common SNPs on a
genome-wide level to identify GxE interactions, in which
natural DNA variation was the genetic perturbation and
Ox-PAPC treatment status was the environmental pertur-
bation. We show that individual responses to Ox-PAPC
were highly variable and that responsiveness to Ox-PAPC
for 32% of the most highly Ox-PAPC regulated transcripts
exhibited regulation by at least one genetic locus.Material and Methods
Cell Culture and Treatment with Ox-PAPC
An overview of the experimental design and subsequent data
processing and analyses are shown in Figure 1 and Figure S1
available online. HAECs were isolated from aortic explants of
heart transplant donors of anonymous origin through the
UCLA transplant program and grown to conﬂuence in 100 mm
dishes as previously described.14 A total of 250,000 cellswere plated
into each well of a standard six-well dish. At 90% conﬂuence,
cells were treated for 4 hr in duplicate with either media alone
or Ox-PAPC-containing media. Treatment media consisted of
Medium 199 (Mediatech, Inc., Manassas, VA) containing 1% fetal
bovine serum. Ox-PAPC treatment media additionally contained
40 ug/ml Ox-PAPC, prepared from PAPC purchased from Avanti
Polar Lipids (Alabaster, AL) as previously described15 and checked
for oxidation by mass spectrometry. Overall, two preparations of
Ox-PAPCwere used in the course of the experiment for prevention
of increased oxidation of the Ox-PAPC over time. The ﬁrst prepara-
tion was used for 47 HAEC donors and was completed within
4 months and the second set of 49 donors were treated and
collected several months later. This ‘‘batch effect’’ was removed in
downstream analysis by normalizing expression values between
groups with COMBAT software.16 Cytoplasmic RNA was extracted
with the RNeasy kit including optionalDNase treatment (QIAGEN,
Valencia, CA). RNA concentrations were measured with the Nano-
Drop 2000 (Thermo Fisher Scientiﬁc, Waltham, MA) and quality
checkedwith theAgilent 2100Bioanalyzer (Agilent, Palo Alto, CA).
Gene Expression and siRNA Experiments
RNA was prepared for hybridization to Affymetrix HT-HU133A
microarrays with a standard protocol described previously.13
Intensity values were normalized with the robust multiarray
average (RMA)17,18 normalization method in R 2.5.0 with the
justRMA function of the affy package of Bioconductor. We utilized
an alternative CDF ﬁle that excluded misaligned probes that were
artifacts of the previous transcriptome build that was used for400 The American Journal of Human Genetics 86, 399–410, March 1creating the publicly available Affymetrix CDF ﬁle. To create an
updated CDF, we used the custom CDF created by Zhang J et.
al.19 that was created for the Affymetrix U133A array. Because of
the differences in the underlying location of probes between the
U133A and HT-U133A arrays, we ﬁrst created a probe-to-probe
map between the arrays. Then we converted the alternate CDF
ﬁle from the U133A format to the HT-U133A format using this
map. No other alterations were made.
Consistent with previous studies that evaluated the genetics
of gene expression with Affymetrix platforms,20,21 we did not
remove probes that had SNPs in them because the quantiﬁcation
of Affymetrix Probe Set IDs (PSIDs) is a reﬂection of multiple
probes that are scattered throughout the targeted transcript. In
the case where a SNP caused differential hybridization between
alleles in one of the probes in a PSID, on average, ten additional
probes would have contributed to the calculation of PSID inten-
sity. It is important that probes containing SNPs are removed in
array platforms in which a single oligonuclotide sequence is
used for quantifying transcripts such as Agilent and Illumina
platforms; however, this a less pertinent issue for RMA-normalized
Affymetrix data.
Probe sets were excluded from local- analysis if they aligned to
multiple locations in the genome that were more than 1Mb apart.
A total of 385 microarrays, corresponding to 96 unique donors,
were used in this study. Sex was determined from heterozygous
genotype calls on the X chromosome and revealed that 73 donors
weremale and 23were female. There were 11 females and 36males
in ‘‘batch 1’’ and 12 females and 37 males in ‘‘batch 2.’’ COMBAT
software16 was used for normalizing expression values for sex and
batch. We did not normalize for treatment in COMBAT because
we wanted to maintain the differences in expression patterns
between control and Ox-PAPC-treated arrays. Treatment condi-
tions were always performed in parallel and were therefore not
confounded by batch. We performed principal component anal-
ysis to identify known technical variables, such as array plate,
row, column, and hybridization date that correlated with PCs.
This analysis showed that the ﬁrst PC was driven by treatment
(control versus Ox-PAPC); however, the other PCs were not
explained by known variables. Transcript expression was used
for clustering the microarray samples and conﬁrmed that no
outlier arrays were used in downstream analysis. Expression values
were averaged between duplicate arrays per condition and donor.
Three expression data sets were used in downstream analysis:
control (i.e., basal), Ox-PAPC-treated values, and the fold change
of Ox-PAPC over basal levels, which was calculated as the
(log2(Ox-PAPC) – log2(basal)) expression values. Equal amounts
of cDNA for qRT-PCR were made with the ABI High Capacity
cDNA Reverse Transcription Kit (Foster City, CA). The Roche2, 2010
LightCycler 480 Master Mix and LightCycler 480 machine (Roche
Diagnostics, Indianapolis, IN) were used for qRT-PCR reactions.
Primer sequences used for qRT-PCR can be found in Table S1.
siRNA experiments were performed as previously described.22
In brief, cells were transfected at 75% conﬂuence for 4 hr with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and 40 nmole of
siRNA (QIAGEN) (sequences found in Table S1). After 24–48 hr,
cells were treated with Ox-PAPC for 4 hr and mRNA was collected
for qRT-PCR or microarrays. ATF4 (MIM 604064) and XBP1 (MIM
194355) knockdown experiment RNA preparations were hybrid-
ized to Illumina Human Ref-8 microarrays and normalized as
previously described.23
SNP Genotypes
Genomic DNA was isolated from HAECs with the DNeasy extrac-
tion kit with optional DNase treatment (QIAGEN) and quantiﬁed
with NanoDrop 2000 (Thermo Fisher Scientiﬁc, Waltham, MA).
All samples were randomly arrayed into three 96-well microtiter
plates at 50 ng/ul. Per Affymetrix Genome wide Human SNPArray
6.0 assay protocol, 2 3 250 ng of gDNA were digested by restric-
tion enzymes NspI and StyI separately and products were ligated
to respective adaptors (Affymetrix Human SNP 6.0 assay). PCR
was used for amplifying ligation products and checked for size
and quality by QIAxcel (QIAGEN). Labeled PCR products were
hybridized to the Human SNP 6.0 array. Array hybridization,
washing and scanning were performed according to the Affyme-
trix recommendations. Scanned images were subjected to visual
inspection and a chip quality report was generated by the Affyme-
trix GeneChip Operating System (command console) and the
Genotyping console (Affymetrix). The image data was processed
with the Affymetrix Genotyping Console or Birdsuite algorithm24
for determining the speciﬁc hybridizing signal for each SNP call
and copy-number detection. SNPs used in association analysis
were ﬁltered according to the following criteria: (1) 296,151 SNPs
were removed with minor allele frequencies (MAF) less than 10%
or from sex chromosomes, (2) 92,316 SNPs were removed that
violated Hardy-Weinberg Equilibrium (p value > 0.05), and (3)
6,250 SNPs were removed that had missing values in >10% of
individuals. The remaining 545,098 SNPs were used for associa-
tion testing of distal- variants. Given that the method of multiple
testing correction used in this study relied on the number of
linkage disequilibrium blocks, and not the number of SNPs, we
could have used a smaller MAF in our eQTL analysis. Had we
used the MAF of 5%, we would have identiﬁed many thousands
of additional eQTLs in the basal and Ox-PAPC data sets. However,
we used the more conservative MAF (10%) in this study to avoid
spurious eQTL that may arise from small samples of heterozyotes
or minor allele homozygotes. All SNP ﬁltering was performed
with the freely downloadable whole-genome association toolkit
PLINK 1.4.25
Because our HAEC population was derived from aortic explants
of anonymous heart transplant donors, we have no individual
information, including ethnicity, history, or disease status. We
therefore sought to ascertain the population structure of our pop-
ulation to ensure that gross population stratiﬁcation would not
cause spurious association results. We tested for population struc-
ture in PLINK by using the ‘‘-clustering’’ function that clusters
individuals on the basis of the IBS sharing of their autosomal geno-
types. This analysis resulted in a single cluster of individuals, sug-
gesting that the individuals in our HAEC population had similar
genetic structure. Further analysis of population structure was
implemented by plotting the ﬁrst two principal components ofThe Amerithe sharing of autosomal genotypes. Visual inspection suggested
that modest population structure existed in our data; however,
removing these samples had little effect of the results of the study
(Figure S2).Association Analysis
Normalized expression values were associated to SNPs using
the –assoc command in PLINK that tests for additive SNP effects.
For local-association testing, only SNPs within the 5500 kb
window measured from the 50 and 30 edges of the transcript
were used. The local- region was extended to51 Mb when search-
ing for local-expression traits that comapped to distal-gxeQTL of
interest. A total of 1000 permutations between each expression
values and local-SNPs determined the empirical locus-wide cor-
rected p values for each SNP. SNPs used for distal- association
included all ﬁltered SNPs outside of the local- region. Five percent
false discovery was determined for basal and Ox-PAPC distal-
association data sets with point-wise thresholds¼ (r/t)*FDR,where
r is the rank based on ascending p values, t is the number of tests,
and FDR is the desired FDR threshold (5%).26 For our data set the
number of tests was 1.278 3 109 (19,092 transcripts 3 66,923 LD
blocks27). When association p values exceeded the calculated
point-wise threshold, we considered the result signiﬁcant at 5%
FDR. In our gxeHotspot analysis distal- associations were consid-
ered when they exceeded 7.47 3 107, corresponding to the
Bonferroni corrected threshold given the number of linkage
disequilibrium blocks estimated from the CEPH HapMap
genome.27 All transcripts were considered for GxE local-gxeQTL,
whereas only transcripts that were regulated by more than an
average of 2-fold by Ox-PAPC (59 transcripts) were considered
when testing for distal-gxeQTL. We chose to focus on the tran-
scripts that were regulated by more than an average of 2-fold by
Ox-PAPC for two reasons. First, highly Ox-PAPC regulated tran-
scripts are likely to have a biological impact in the Ox-PAPC
response and are therefore likely to be an important source of vari-
ation between donors. Second, limiting the number of transcripts
included in distal-GxE analysis reduced the burden of multiple
testing to enable our detection of true positives.Results
Evidence for Genetic Control of Basal Gene Expression
and Expression Responsiveness to Ox-PAPC
To directly observe gene expression variation in our popu-
lation of 96 primary HAECs, we measured transcript levels
for control and Ox-PAPC-treated cultures. To test for
repeatability in expression values to ensure that expression
variation among HAEC donors was stable and not due to
technical variation, we selected the 100 most variable
transcripts across all donors. Then we analyzed the correla-
tions for these 100 genes between (1) ten independent
culture pairs from separate passages of cells that originated
from the same donor and (2) 43 random pairings of
cultures from different donors. We tested for repeatability
in gene expression for three expression data sets after
normalization: expression measured at baseline, expres-
sion measured after Ox-PAPC treatment, and the indi-
vidual response values calculated as Ox-PAPC treated/
untreated. All three data sets demonstrated repeatabilitycan Journal of Human Genetics 86, 399–410, March 12, 2010 401
Figure 2. Expression Variation in the HAEC Population
Gene expression intensity (y axis) for the indicated transcripts are
shown for basal (solid black circles) and Ox-PAPC-treated (open
red circles). Variations in the HAEC population are shown in (A)
for transcripts KCNAB1 (left) and ERAP2 (right) in which basal
levels were variable but unresponsive to Ox-PAPC. In (B), expres-
sion variation in HMOX1 (top) and GJA5 (bottom) are shown
frommicroarrays (left) and with RT-PCR (right). Variation in these
transcripts was greater at baseline compared to after Ox-PAPC
treatment. Transcripts KLF4 (left) and CHAC1 (right), whose
Ox-PAPC treated expression was more variable than basal levels,
are shown in (C). Donors are rank ordered by basal expression
along the x axis and expression values are on a log2 scale (y axis).for intraindividual pairs relative to interindividual pairs
(Figure S3). Calculated from the 100 most variable genes
in their basal levels, we found that intra-individual expres-
sion was replicated on different passage (R ¼ 0.721, p <
2.2e16), whereas inter-individual expression was not
correlated (R ¼ 0.007, p ¼ 0.657). The same trend was
observed for expression of the 100 most variable genes
after Ox-PAPC treatment (intra: R ¼ 0.698, p < 2.2e16,
inter: R ¼ 0.016, p ¼ 0.280) and the individual fold
change values caused by Ox-PAPC of the 100 most variable
transcripts (intra: R ¼ 0.158, p ¼ 5.0e7, inter: R ¼ 0.008,
p ¼ 0.618). To formally test for repeatability in gene
expression signatures, we compared the R2 value distribu-
tions for the 1000 most variable genes between intraindi-
vidual pairs and 43 random interindividual pairs (Fig-
ure S4A). Expression was signiﬁcantly more similar within
as compared to between donors for basal (p < 2.2 3
1016), Ox-PAPC-treated (p < 2.2 3 1016), and individual
Ox-PAPC-induced fold change values (p < 2.2 3 1016) as
determined by t test. As expected, duplicate arrays were
highly correlated (Figure S4B).
Basal expression values as well as individual responses to
Ox-PAPC were variable in our HAEC population (Figure 2).
Expression patterns fell into several different classes:
17,582 transcripts were not affected by Ox-PAPC across
all individuals (examples in Figure 2A), 1,510 transcripts
were altered by an average of at least 1.2-fold by Ox-PAPC,
261 transcripts were altered by at least 1.5-fold, and 59
were altered on average by more than 2-fold (examples in
Figures 2B and 2C). Responsive transcripts were deter-
mined by a two-sided paired t test between control and
Ox-PAPC measurements. These observations met a 5%
false discovery rate (FDR), meaning that up to 5% of these
results could have been deemed signiﬁcant by chance.
There is a large overlap in the genes identiﬁed to be regu-
lated by Ox-PAPC in this study and that reported previ-
ously.13 Seventy-four percent of the transcripts that were
differentially expressed by more than 1.5-fold in this
study had been previously reported in the analysis of 12
HAEC donors. Discrepancies between the studies may be
due to different preparations of Ox-PAPC, culturing condi-
tions, and sample sizes. These data conﬁrm that Ox-PAPC
robustly regulates transcription in ECs.
HAECGene Expression Regulation by Local and Distal
Genetic Variants
To test whether common genetic polymorphisms ex-
plained differences in gene expression, we genotyped each
primary HAEC culture using the Affymetrix 6.0 SNP
platform. For this analysis, the ~1million SNPs on the array
were ﬁltered to a working set of 545,098 autosomal SNPs
by removal of SNPs that (1) exhibited less than 10%
minor allele frequency, (2) violated Hardy-Weinberg equi-
librium, and (3) had more than 10% missing values. Three
data sets were used for expression-based whole-genome
association: (1) basal gene expression, (2) expression for
cells treated with Ox-PAPC, and (3) the change in gene402 The American Journal of Human Genetics 86, 399–410, March 1expression trait values caused by Ox-PAPC-treatment (also
called ‘‘response’’ to Ox-PAPC). Signiﬁcant associations
identiﬁed in the latter data set were deﬁned as gxeQTL
because they reﬂect genetic variation that associated with
individual variability in the environmentally induced
(Ox-PAPC) changes in gene expression trait values (dis-
cussed below). The series of data analysis we performed
are outlined in Figure S1.
One unique characteristic of gene expression pheno-
types is that they have a physical address in the genome.
This provides the opportunity to deﬁne two distinct
types of expression associations: local-expression quantita-
tive trait loci, abbreviated as local-eQTL (commonly also
referred to as cis-), and distal-expression quantitative trait2, 2010
Figure 3. HAEC Gene Expression Is
Genetically Regulated by Local Variants
Expression of KCNAB1 in untreated (solid
circles) and Ox-PAPC-treated (open circles)
samples are shown in (A). Donors are
across the x axis in order of increasing
basal expression and colored according to
genotypes at the local-eQTL rs6775600.
The right-hand plot shows basal transcript
values of KCNAB1 as a function of geno-
type at the same SNP. In (B), expression
of ERAP2 is shown according to the same
schema described in (A) for local-associa-
tion to rs27290, and for four additional
genes (CAP2 [MIM 601697], NDUFAF1
[MIM 606934], AP3S2 [MIM 602416],
and ANAPC13) with respective local-
eQTL in (C). (D) shows the local-gxeQTL
rs7135847 association to expression levels
of FGD6 at basal and after Ox-PAPC treat-
ment (left panel) with the same schema
described in (A) and (B). The right panel
shows the log2 fold regulation of FGD6
upon Ox-PAPC treatment as a function of
genotypes at rs7135847.loci, abbreviated as distal-eQTL (commonly also called
trans-) (reviewed in Rockman and Kruglyak28). Local
regions were deﬁned in this study as SNPs in the range of
500 kb upstream to 500 kb downstream of the physical
location of the regulated trait. Distal-eQTL were those
outside the local- region. We chose to use the terms local-
and distal-, rather than cis- and trans-, because we feel
they are more accurate (as discussed by Rockman and
Kruglyak28) and avoid any confusion microbiologists and
other nongeneticists may have with the terms cis- and
trans-.
The number of SNPs per local- region ranged from 1 to
1398 (mean ¼ 187.5, median ¼ 182). In our HAEC data
set, 2,668 expression traits had at least one signiﬁcant
local-eQTL for basal expression at a locus-wide empirical
signiﬁcance level less than 0.05. Additionally, for expres-
sion valuesmeasured after Ox-PAPC treatmentwe observed
2,766 signiﬁcant associations. As measured by regres-
sion R2, the proportion of variation in expression trait
values by single local-eQTL ranged from 23%–84% (mean
34%) (Figure S5). These data are consistent with themagni-The American Journal of Human Gtude of local-expression associations
found in other studies of similar
size10,20,29–31 and conﬁrmed our
hypothesis that basal gene expression
traits were genetically regulated in our
HAEC population. Half of the tran-
scripts with local- regulators of basal
expression levels also showed local-
regulation in their Ox-PAPC-treated
values (Figure S6).
KCNAB1 (MIM 601141) and ERAP2
(MIM 609497) are examples of genes
not regulated by Ox-PAPC that showhighly signiﬁcant local-eQTL for basal expression levels
(Figures 3A and 3B). KCNAB1 basal levels exhibited a
16-fold difference in expression between HAEC donors
homozygous for minor versus major alleles of rs6775600
(p value ¼ 1.07 3 1035). The regression coefﬁcient (R2)
for this eAssociation was 0.81, demonstrating nearly
Mendelian regulation of KCNAB1 transcript levels by local
variation. A fold change of similarmagnitude was observed
between HAEC donors carrying different genotypes at the
ERAP2 local-eQTL rs27290 (R2 ¼ 0.84, p value ¼ 1.68 3
1038). Additional examples of local-eQTL for basal expres-
sion are shown in Figure 3C. These data conﬁrm that
expression was strongly inﬂuenced by common genetic
variation in our system and provide an atlas of local-regula-
tory relationships in a primary vascular cell type.
Distal-genetic regulation of expression has been reported
in various association studies; however, the effect sizes of
distal- regulation are generally smaller and thus more difﬁ-
cult to detect relative to local- regulation. Nonetheless, we
were able to detect signiﬁcant evidence of genetic regula-
tion of expression traits by distal variants. At a 5% FDR,enetics 86, 399–410, March 12, 2010 403
Table 1. Basal and OxPAPC-Treated Expression Traits Are
Regulated by Distal Variants
Transcript/
Distal-eQTL pairs Distal-eQTL Transcripts
Unique Gene
Symbols
Basal 6696 5494 2978 2584
OxPAPC 8243 6571 3684 3150
The number of significant transcript distal-eQTL pairs is shown at 5% FDR. For
these associations, the corresponding number of eQTL, transcripts (probe sets
from the microarray), and the corresponding number of unique genes are
shown.
Table 2. Evidence for local-gxeQTL
Locus-wide
a Significance
Significant
Transcripts (Expected
False Positives)
Significant
Genes (Expected
False Positives)
0.001 38 (18) 37 (12)
0.01 253 (184) 247 (118)
0.05 1069 (918) 1005 (592)we identiﬁed 6696 distal- associations for basal expression
(Table 1). The FDR procedure we implemented would not
account for strong p values that occur as a result of outliers.
It would have been optimal to perform two-way SNP and
transcript permutation analysis to adjust for the validity
of each transcript’s distal proﬁle; however, this was not
feasible given the number of SNPs and traits in our
data set. For this reason, we chose a conservative MAF of
10% so that our association results would be less prone
to the effects of outliers. The proportion of trait variation
explained by single distal-eQTL ranged between 23%–
61% for basal expression data (Figure S5). This includes
the full set of unique transcript/eQTL association pairs
and therefore includes situations in which transcripts asso-
ciated to multiple distal-eQTL and in which distal-eQTL
associated to many transcripts. For basal transcript levels,
5494 unique eQTL were associated with at least one tran-
script, and 2978 transcripts showed distal- regulation by
at least one eQTL. The number of post-Ox-PAPC measured
expression distal- associations were on the same order as
those observed for basal expression traits (Table 1). These
data clearly show that distal- variants robustly regulated
endothelial gene expression and furthermore provide a
detailed atlas of distal-regulatory relationships for this
specialized human cell type.
To investigate whether SNPs underlying probe se-
quences may have created ‘‘ghost eQTLs’’ in our data, we
examined the distribution of SNP-containing probe sets
among our eQTL results for basal expression. This was
calculated with the full set of SNPs in dbSNP 129, many
of which are rare and thus unlikely to be polymorphic in
our population. We identiﬁed the same proportion of
probe sets with SNPs in signiﬁcant eQTLs as in nonsignif-
icant eQTLs. Speciﬁcally, 69% of eQTLs contained at least
one probe containing a SNP per probe set for both signiﬁ-
cant and nonsigniﬁcant eQTLs. These data suggest that
SNPs in probe sets did not affect our eQTL results.
Gene-by-Environment Interactionwith Local Variants
To ﬁnd genetic variations associated to individual gene
responsiveness to Ox-PAPC treatment, and thus GxE
interactions, we tested for local-gxeQTL in our population
of HAECs by associating SNPs to individual Ox-PAPC-
induced fold changes of transcripts. We chose to perform
the association analysis as described because it was an404 The American Journal of Human Genetics 86, 399–410, March 1intuitive way to test for GxE associations. A thousand
permutations in each local region (500 kb up to 500 kb
down of transcripts) determined the empirical locus-wide
signiﬁcance values. A total of 1,005, 247, and 37 unique
genes had respective local-gxeQTL at locus-wide signiﬁ-
cance thresholds of 0.05, 0.01, and 0.001 (Table 2). These
results corresponded to more signiﬁcant observations
than would be expected by chance, indicating that local-
gxeQTL played a role in individual Ox-PAPC responsive-
ness. However, the false discovery rate of these observa-
tions is high (59%, 48%, and 32%), making it difﬁcult to
conclude how common local-gxeQTL are in regulating
expression. The seven most signiﬁcant local-gxeQTL asso-
ciations are listed in Table S2.
The fold induction of FGD6 was the most signiﬁcant
local-gxeQTL in our data set (p value ¼ 9.9 3 1026)
(Figure 3D). FGD6 is thought, by sequence homology,
to be a Rho family guanine nucleotide exchange factor
(RhoGEF) that catalyzes GDP/GTP exchange for small
G proteins involved in cytoskeletal pathways. rs7135847
was the peak gxeQTL located within the second intron
of FGD6 within linkage disequilibrium of the FGD6
promoter and several lesser-associated gxeQTL. In the
case of FGD6, both basal and Ox-PAPC treated levels were
genetically controlled. Thus, cells from individuals with
the AA genotypes exhibited signiﬁcantly lower levels of
expression than cells from AG or GG individuals. Upon
treatment with Ox-PAPC, AA cells showed decreased
expression, whereas AG or GG cells showed increased
expression, representing a striking example of a local-
gene-by-environment interaction and evidence of a local-
regulatory element that modiﬁes Ox-PAPC responsiveness
in ECs.
Evidence of Gene-by-Environment Interactions
for Distal Variants
On the basis of studies in yeast8 and human lymphoblas-
toid cell lines,10 we hypothesized that most of the gxeQTL
that regulate individual responses to Ox-PAPC treatment
would be distal- as opposed to local- variants. To test
this hypothesis, we focused on the 59 expression traits
(corresponding to 49 unique transcripts) that were an
average of at least 2-fold regulated by Ox-PAPC across our
HAEC population. Thirty-two percent of these transcripts
exhibited at least one signiﬁcant distal-gxeQTL association
at 5% FDR. In total, 21 unique gxeQTL were associated
to 19 transcripts (corresponding to 18 unique genes)2, 2010
(Table S3). The amount of variation in the fold change of
a given transcript explained by single gxeQTL ranged
from 24%–32%, indicating that a quarter or more of the
variability in responsiveness to Ox-PAPC could be attrib-
uted to single loci for these transcripts. Three of the 21
distal-gxeQTL were located in LD blocks containing genes.
The remaining distal-gxeQTL were in intergenic LD blocks
not containing genes. One such gxeQTL, associated to the
Ox-PAPC response values of ENC1 (MIM 605173), was
within clear linkage disequilibrium of two genes, GPX2
(MIM 138319) and RAB15 (MIM 610848). Of these two
candidates, only RAB15 was highly expressed in HAECs.
Whereas most gxeQTL were only associated to one expres-
sion trait, distal-gxeQTL rs2831649 was associated to the
Ox-PAPC response of seven expression traits, thus identi-
fying a locus on chromosome 21 as an important putative
regulator of Ox-PAPC responsiveness for several transcripts
(discussed below).
Distal regulation of expression traits is likely to occur
through the action of an intermediate gene product. We
therefore sought to better prioritize candidate causal genes
located at distal- loci, and responsible for the distal- signal,
by asking whether distal-gxeQTL also associated to local
transcript levels. Locally associated expression traits would
thenbe strong candidates for theobserved changes in target
expression traits at distal- loci. In scanning for local-associ-
ated transcripts, we extended the local search criteria to
span 1Mbupstream to 1Mbdownstreamof transcriptional
start sites and considered associations to basal, Ox-PAPC, or
response values of local transcripts. Ox-PAPC-treated
expression levels of USP16 (ubiquitin speciﬁc peptidase
16 [MIM 604735]) showed evidence (nominal p value ¼
3.3 3 105) of local-expression association to rs2831649,
the aforementioned distal-gxeQTL on chromosome 21
that associated to 7 expression traits (Figure S7). Another
distal-gxeQTL, rs2412524, which associated to the Ox-
PAPC response values of NAV3 (MIM 611629), showed
evidence of local-association to two local transcripts: one
83,475 bp downstream of the SNP, IVD (isovaleryl coen-
zyme A dehydrogenase, [MIM607036]) (nominal p value¼
4.6 3 105), and the other 266,809 bp downstream of
the SNP, DNAJC17 (DnaJ homolog subfamily C member
17) (nominal p value ¼ 3.2 3 104). Both of these local-
associations to gxeQTL rs2412524 were for the basal
levels of local transcripts, suggesting a mechanism in
which baseline expression differences would determine
the Ox-PAPC inducibility of target genes at distal- loci.
The remaining distal-gxeQTL lacked local- candidates and
ranged in distance from 28,508 to 809,716 base pairs to
the nearest transcript. Four genes (HMOX1 [MIM 141250],
SLC7A11 [MIM 607933], VEGFA [MIM 192240], and
TRIB3 [MIM 607898]) exhibited distal-gxeQTL associations
at two unique loci, whereas all other genes were associated
to one distal-gxeQTL (Table S3).
One pattern suggestive of GxE regulation that we
observed for Ox-PAPC-regulated genes was greater varia-
tion across donors in basal expression relative to Ox-The AmeriPAPC-treated values (n ¼ 180) (examples in Figure 2B). In
contrast, Ox-PAPC-treated levels were generally more vari-
able than the corresponding basal values (n ¼ 530) (exam-
ples in Figure 2C) (Figure S8). Heme oxygenase 1 (HMOX1)
was an example of a gene in which the basal expression
varied widely among the individuals studied, with more
than a 10-fold difference between the extremes (Figure 2B,
top-left panel). Ox-PAPC treatment resulted in a dramatic
induction of HMOX1 in these individuals, ranging from
~2-fold to 16-fold. However, the levels of HMOX1 tran-
script in the induced state were very similar among all indi-
viduals and showed no relationship to basal levels. For the
case of GJA5 (MIM 121013), basal levels again varied
considerably, but Ox-PAPC treatment caused a decrease
in expression such that all individuals exhibited similar
levels, independently of baseline expression (Figure 2B,
bottom-left panel). Our observation that Ox-PAPC induced
HMOX1 expression to reach a maximum value and
reduced GJA5 expression to a minimum value could have
been due to technical artifacts such as saturation of
the array capture probes or by a limited dynamic detec-
tion range of arrays. We tested this possibility by perform-
ing quantitative RT-PCR, which is not limited by the
same constraints, on a subset of individuals. qRT-PCR for
HMOX1 conﬁrmed that Ox-PAPC induced HMOX1 to
similar levels for all individuals regardless of baseline
expression, suggesting that there was a biological limit to
the amount of HMOX1 cells produced after treatment
(Figure 2B, top-right panel), conﬁrming that HMOX1
expression after treatment does not appear to be geneti-
cally regulated but environmentally regulated. qRT-PCR
for GJA5 conﬁrmed that basal expression was not pre-
dictive of the degree of Ox-PAPC-dependent downregula-
tion; however, the limited sensitivity of the arrays, as
compared to qRT-PCR appeared to contribute to the level
of downregulation by Ox-PAPC (Figure 2B, bottom-right
panel).
Genotype x Ox-PAPC-Dependent Regulatory Hotspots
We tested for large-scale differences in genetic transcript
regulation that were condition dependent. To be more
inclusive when looking for widespread regulation, we
considered all distal-eQTL where p < 7.47 3 107, which
corresponded to the transcript-speciﬁc Bonferroni correc-
tion threshold for the number of estimated unique linkage
disequilibrium blocks interrogated by SNP array platforms
in the human genome.27 Genomic loci that showed condi-
tion-speciﬁc associations for several expression traits were
designated genotype 3 Ox-PAPC-dependent regulatory
hotspots (gxeHotspots). Six gxeHotspots explained varia-
tion in responsiveness for ten ormore transcripts (Figure 4).
The most pronounced gxeHotspot associated to the Ox-
PAPC-induced response for 33 transcripts. This was the
same gxeQTL on chromosome 21 that associated to seven
highly Ox-PAPC-regulated genes from our distal- analysis
and was locally associated to the expression levels of
USP16. The only additional gxeHotspot that exhibitedcan Journal of Human Genetics 86, 399–410, March 12, 2010 405
Figure 4. gxeHotspots
gxeHotspot lociwere determined by count-
ing the number of transcripts (y axis)
whose response to Ox-PAPC comapped to
gxeQTL across the autosomes (x axis).
gxeAssociations with p < 7.47 3 107
were considered in this analysis.regulation for a local- candidate was rs6743090 on chromo-
some 2 that locally associated to basal, Ox-PAPC, and
Ox-PAPC-responsive values ofMCM6 (MIM 601806) (Table
S4), suggesting a role forMCM6 in regulating the Ox-PAPC
inducibility of multiple targets.
USP16 Modulates Ox-PAPC Induction of Target Genes
Involved in the UPR
To test the hypothesis thatUSP16 (a histone H2A deubiqui-
tinase) regulated Ox-PAPC responsiveness for the seven
highly induced Ox-PAPC genes identiﬁed in our distal-
analysis, we used an RNAi approach. The Ox-PAPC fold
induction for all seven target genes (ASNS [MIM 108370],
CEBPB [MIM 189965], SLC7A11, SLC7A5 [MIM 600182],
SLC3A2 [MIM 158070], TRIB3, and VEGFA) of gxeQTL
rs2831649 were measured after transfection by two unique
siRNAs against USP16 and compared to the scrambled
control. USP16 transcript levels were reduced to ~15% of
control levels by USP16 siRNA1 and in 10% of control
levels with siRNA2 (Figure 5A). Six of the seven transcripts
(all but VEGFA) were induced by more than 2-fold by
Ox-PAPC in the HAEC donor in this experiment. The G
allele of rs2831649 was associated with higher USP16
expression as well as greater Ox-PAPC-induced fold
changes of target genes. We therefore expected that USP16
knockdown would reduce the Ox-PAPC effect on target
genes. As expected, the Ox-PAPC-induced fold change for
ﬁve of these genes were reduced upon USP16 knockdown
by at least one siRNA, whereas four targets exhibited
reduced Ox-PAPC inducibility by both USP16 siRNAs (Fig-
ure 5B). IL8 [MIM 146930] and LDLR [MIM 606945], two
additional genes known to be induced by Ox-PAPC but
whose Ox-PAPC response did not associate to rs2831649,
were included as negative controls. Ox-PAPC-response
values for IL8 and LDLR were not signiﬁcantly reduced
by USP16 knockdown, demonstrating that USP16 selec-
tively modulates the Ox-PAPC inducibility of predicted
target genes.
The seven genes associated to gxeHotspot rs2831649
have been shown to respond to amino acid depriva-
tion,32,33 and some to the UPR stress response,23,33–35
which is known to be induced by Ox-PAPC in this cell406 The American Journal of Human Genetics 86, 399–410, March 12, 2010type.22 Many of these molecules are
regulated by or interact with acti-
vating transcription factor 4 (ATF4),
a UPR-activated transcription factor
that coordinates one of the UPR
response pathways32,34–36 To testwhether the Ox-PAPC fold induction values of these tran-
scripts were regulated by two important UPR transcription
factors, ATF4 and X-box binding protein (XBP1), which
coordinate stress response pathways, we utilized microar-
ray data collected after siRNA knockdown with and
without Ox-PAPC treatment. ATF4 and XBP1 were both
silenced by more than 70% of their control values (Fig-
ure S9). Of the seven targets, VEGFA was not signiﬁcantly
detected on the array. Four of the remaining six transcripts
(ASNS, CEBPB, SLC7A5, and TRIB3) exhibited reduced
Ox-PAPC-induced fold changes after ATF4 and XBP1
knockdown, suggesting that these genes are either direct
or indirect targets of both transcription factors (Table 3).
Together, these data support the hypothesis that variation
at the chromosome 21 gxeHotspot locus, probably acting
through USP16, coordinates cellular responses to ER stress
that involves ATF4 and XPB1 transcription factors.
Discussion
We have investigated the nature of GxE interaction in the
human population by monitoring global expression traits
in HAECs after perturbation with biologically active lipids.
HAECs, obtained from 96 heart transplant donors, were
subjected to genotyping with high-density SNP arrays,
enabling transcript responses to be associated with speciﬁc
polymorphisms in the genome. Our experimental design
enabled the identiﬁcation of GxE interactions because we
utilized a diverse human population of vascular cells that
were treated by a clinically relevant perturbation in a
controlled environment. Our results show that GxE inter-
actions are common in the human population, consistent
with previous studies in yeast and worms, and they reveal
several different classes of interactions.
We ﬁrst demonstrated strong evidence that the gene
expression in primary HAECs, both in the basal state
and after treatment with Ox-PAPC, were heritable. Thus,
when the responses of cells from a single individual were
examined in different passages, they were signiﬁcantly
correlated, whereas the responses from different individ-
uals were not correlated (Figures S3 and S4). These
results could be explained by epigenetic as well as genetic
Table 3. ATF4 and XPB1 Silencing Affects OxPAPC Inducibility
of gxeHotspot rs2831649-Associated Genes
Gene
Symbol
Scr Fold
Change
(stdev)
ATF4 siRNA
Fold Change
(stdev)
ATF4
siRNA
p Value
XBP1 siRNA
Fold Change
(stdev)
XBP1
siRNA
p Value
ASNS 2.41 (0.24) 1.22 (0.03) 0.0001 1.88 (0.14) 0.0094
CEBPB 2.75 (0.23) 1.43 (0.18) 0.0001 1.65 (0.26) 0.0007
SLC7A5 3.15 (0.17) 1.79 (0.25) 0.0001 2.46 (0.21) 0.0022
TRIB3 2.67 (0.29) 1.65 (0.13) 0.0007 1.71 (0.10) 0.0009
Figure 5. USP16 Regulates Target Gene Responsiveness to
Ox-PAPC
(A) USP16 mRNA message levels were measured by qRT-PCR and
normalized to the housekeeping gene B2M after transfection
with the scrambled control and two USP16 siRNAs in HAECs.
(B) The Ox-PAPC-fold induction for six target genes and the nega-
tive control genes IL8 and LDLR. Averages 5 SD are shown for
both (A) and (B).differences. We further observed that a signiﬁcant fraction
of variability in transcript levels could be attributed to
genetic loci, some exhibiting essentially Mendelian expec-
tations (Figure 3). The high heritability of expression
traits has previously been observed in studies of related
individuals and populations for primary lymphocytes,30
lymphoblastoid cell lines,20,21,37–39 brain cortex,40 osteo-
blasts,41 T cells,37 ﬁbrobalsts,37 liver biopsies,42 and adi-
pose biopsies29 of humans.
The key ﬁnding of our study is that there were very
signiﬁcant interactions between genotype and response
to Ox-PAPC for approximately one-third of the most
highly regulated expression traits. Many such GxE interac-
tions involved distal- regulation, but we also observed
some local-GxE interactions (Figure 3D and Table 2), indi-
cating that although infrequent, local sequences have
the potential to greatly perturb environment-dependent
phenotypes. These results are consistent with those from
genetic crosses between different strains of yeast8 and
human lymphoblastoid cell lines treated with ionizing
radiation.10 In our study, the most signiﬁcant local-gxeQTL
was for a variant of FGD6 (p value¼ 9.55e22) (Figure 3D),
suggesting that this gene harbors an Ox-PAPC-response
element. Such an element has yet to be identiﬁed given
that cloning of the proximal FGD6 promoter (1898 to
þ224) into a luciferase reporter showed no difference
between alleles in HAECs (data not shown).The AmeriWe identiﬁed gxeHotpspot loci that associated distally to
the Ox-PAPC fold induction of multiple transcripts. Of
particular interest was the gxeHotspot on chromosome
21 that associated to the Ox-PAPC responsiveness for seven
(12%) of the most highly Ox-PAPC regulated transcripts.
We identiﬁed that USP16 was locally associated with this
locus, thereby making it a strong causal candidate. Regula-
tion of target gene responsiveness to Ox-PAPC, mediated
by USP16, was validated with siRNA knockdown, which
impaired the responsiveness of all induced targets in at
least one siRNA condition (Figure 5). USP16 is a histone
H2A deubiquitinase that has been described in regulating
progression through the cell cycle.43,44 Functionally, tran-
script response traits that map to the chromosome 21
gxeHotspot are known to be regulated by amino acid
homeostasis and other ER stress stimuli, including Ox-
PAPC.32–36 We conﬁrmed that the Ox-PAPC response of
these expression traits were regulated by the UPR transcrip-
tion factors ATF4 and XBP1 (Table 3 and Figure S9). Taken
together, our data suggest that variation at gxeHotspot SNP
rs2831649 modulates the Ox-PAPC fold change in UPR
genes, through the action of USP16. It remains unclear
whether USP16 is the sole functional element at the
chromosome 21 gxeHotspot locus or whether additional
regulatory elements also modulate ER stress pathways.
Variation at the rs2831649 locus is not in clear LD with
the proximal promoter of USP16 (Figure S7B), making
the mechanism of local-gxeAssociation difﬁcult to deter-
mine. It is possible that a USP16 enhancer is located near
rs2831649. This explanation is consistent with the obser-
vation that many SNPs identiﬁed in GWAS studies do
not reside in LD blocks that containing genes,45 as is the
case with the widely replicated heart disease locus on
9p2146,47 and has been described to occur more frequently
with tissue-speciﬁc gene expression traits.37 USP16 expres-
sion is highly correlated with several of the targets,
however, supporting the hypothesis that USP16modulates
target expression. An attractive hypothesis is that USP16
could alter chromatin structure upon Ox-PAPC treatment
to enable the selective transcription of UPR genes such as
ATF4 and XBP1 that orchestrate the ER stress response.
The most common GxE interaction pattern we observed
for expression traits was little or no variation in the basal
state but differences in the transcript level after Ox-PAPC
treatment (Figure S8). In some cases, as in the FGD6can Journal of Human Genetics 86, 399–410, March 12, 2010 407
example above (Figure 3D), local-eQTL regulating basal
transcript levels also exhibited regulation for the Ox-PAPC
response pattern for the same transcript. In other cases,
local-eQTL for Ox-PAPC levels exhibited shared regulation
for transcript responses to Ox-PAPC, whereas some local-
gxeQTL were not shared in either basal nor Ox-PAPC
data sets (Figure S6). One form of GxE interaction involved
an apparent limit to the level of induction or repression
by Ox-PAPC. For example, HMOX1 expression varied
widely in the basal state, but upon treatment with Ox-
PAPC, all donor cells exhibited similar levels of expression
(Figure 2B).
The number of eQTL identiﬁed in our study is larger
than in studies of eQTL in HapMap lymphoblastoid cell
lines.20,21,38,39 We are not surprised, however, at the detec-
tion of more regulation because lymphoblastoid cells
have limitations for this type of study. Speciﬁcally, lym-
phoblastoid cells are transformed, which probably causes
degradation of genetic regulators.48 On the contrary, our
population of cells was early passage primary cells. Other
studies conducted in primary, nontransformed cells and
tissue have found genetic regulation of similar numbers
of expression traits. For example, we report that 13.5% of
transcripts have a local-eQTL for basal expression levels.
At a 5% FDR, Emilsson et al.29 reported that 11.5% of
tested expression traits had a local-eQTL in blood and
14.6% of the traits had a local-eQTL in adipose samples
that were both collected from 150 unrelated subjects. As
a control to show that we detected true local- signals, we
plotted the peak local-eQTL location relative to the tran-
scription start site (TSS) (Figure S10) and found that most
local-eQTL occur within 100 kb of the TSS, consistent
with variation in proximal promoters that alter transcrip-
tional activity.31 Pastinen et. al.49 assessed the reproduc-
ibility of expression traits between genetics of expression
studies and showed that overall lymphoblastoid expres-
sion proﬁles are poorly reproducible. Speciﬁcally, they
compare the expression proﬁles of lymphoblastoid cell
mRNA, as measured by (1) biological replicates that origi-
nated from the same donor but were processed by separate
laboratories and hybridized to the same Affymetrix
probe sets in different laboratories and (2) technical repli-
cates that were hybridized to Affymetrix GeneChips. Bio-
logical replicates for the signiﬁcantly heritable transcripts
showed an R2 of ~0.2. Biological replicates are much
more correlated in our data (R2 ¼ 0.721 for basal and
0.678 for Ox-PAPC) (Figure S3). Technical replicates, origi-
nating from separate cell-culture wells and processed inde-
pendently, were also much tighter than previous reports
(Figure S4B) with the R2 > 0.990 for basal and Ox-PAPC-
treated expression measures.
Our study design will enable the elucidation of Ox-PAPC
action in ECs as a model for the complex process of athero-
sclerosis. To date, endothelial pathways are known to be
affected by Ox-PAPC treatment, including inﬂammatory
gene expression,50 coagulation,51 junction formation,52
vasodilation,53 angiogenesis,54 the unfolded protein408 The American Journal of Human Genetics 86, 399–410, March 1response,13,23 and plasma membrane electron transport.55
Our data set should be useful in elucidating the speciﬁc
relationships between these pathways in a single cell
type relevant to complex disease.
GWA studies, over the past 2 years, have identiﬁed
numerous loci contributing to common diseases, but these
generally explain a small fraction of the genetic compo-
nent in disease.2 There are several likely explanations,
including the importance of relatively rare variation that
would not be detected in such studies56 and the presence
of gene-gene interactions.57 Given the difﬁculty of assess-
ing environmental factors in typical human studies, the
presence of GxE interactions would greatly reduce power
to detect important susceptibility loci. Our ﬁndings are
consistent with studies of GxE interactions in lower organ-
isms and suggest that GxE interactions affecting gene
expression may be a common and important attribute of
complex disease.Supplemental Data
Supplemental Data include ten ﬁgures and four tables and can be
found with this article online at http://www.ajhg.org.Acknowledgments
This research was funded by NIH grant PO1-HL030568 (A.J.L. and
J.A.B.), NIH training grant HL069766 (C.E.R.), an American Heart
Association pre-doctoral fellowship (C.E.R.) and an American
Heart Association postdoctoral fellowship (S.D.L.). We would like
to thank the Atherosclerosis Research Unit (ARU) at UCLA for
help collecting the HAECs and Calvin Pan for data management.
R.Y., C.T., B.G., A.H., P.S.G., and T.G.K. are employees and share-
holders of Bristol-Myers Squibb.
Received: October 7, 2009
Revised: January 21, 2010
Accepted: February 2, 2010
Published online: February 18, 2010Web Resources
The URLs for data presented herein are as follows:
Bioconductor, http://www.bioconductor.org/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim
PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/
R, http://www.r-project.org/Accession Numbers
The microarray data used in this study has been deposited in GEO
(accession number GSE20060).References
1. Ioannidis, J.P., Thomas, G., and Daly, M.J. (2009). Validating,
augmenting and reﬁning genome-wide association signals.
Nat. Rev. Genet. 10, 318–329.2, 2010
2. Hardy, J., and Singleton, A. (2009). Genomewide association
studies and human disease. N. Engl. J. Med. 360, 1759–1768.
3. Talmud, P.J. (2007). Gene-environment interaction and its
impact on coronary heart disease risk. Nutr. Metab. Cardio-
vasc. Dis. 17, 148–152.
4. Caspi, A., Sugden, K., Mofﬁtt, T.E., Taylor, A., Craig, I.W.,
Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite,
A., and Poulton, R. (2003). Inﬂuence of life stress on depres-
sion: Moderation by a polymorphism in the 5-HTT gene.
Science 301, 386–389.
5. Mackay, T.F., Stone, E.A., and Ayroles, J.F. (2009). The genetics
of quantitative traits: Challenges and prospects. Nat. Rev.
Genet. 10, 565–577.
6. Ulrich, C.M., Kampman, E., Bigler, J., Schwartz, S.M., Chen,
C., Bostick, R., Fosdick, L., Beresford, S.A., Yasui, Y., and Potter,
J.D. (1999). Colorectal adenomas and the C677TMTHFR poly-
morphism: Evidence for gene-environment interaction?
Cancer Epidemiol. Biomarkers Prev. 8, 659–668.
7. Perlstein, E.O., Ruderfer, D.M., Roberts, D.C., Schreiber, S.L.,
and Kruglyak, L. (2007). Genetic basis of individual differences
in the response to small-molecule drugs in yeast. Nat. Genet.
39, 496–502.
8. Smith, E.N., and Kruglyak, L. (2008). Gene-environment inter-
action in yeast gene expression. PLoS Biol. 6, e83.
9. Li, Y., Alvarez, O.A., Gutteling, E.W., Tijsterman, M., Fu, J.,
Riksen, J.A., Hazendonk, E., Prins, P., Plasterk, R.H., Jansen,
R.C., et al. (2006). Mapping determinants of gene expression
plasticity by genetical genomics in C. elegans. PLoS Genet.
2, e222.
10. Smirnov, D.A., Morley, M., Shin, E., Spielman, R.S., and
Cheung, V.G. (2009). Genetic analysis of radiation-induced
changes in human gene expression. Nature 459, 587–591.
11. Lusis, A.J. (2000). Atherosclerosis. Nature 407, 233–241.
12. Berliner, J.A., and Watson, A.D. (2005). A role for oxidized
phospholipids in atherosclerosis. N. Engl. J. Med. 353, 9–11.
13. Gargalovic, P.S., Imura, M., Zhang, B., Gharavi, N.M., Clark,
M.J., Pagnon, J., Yang, W.P., He, A., Truong, A., Patel, S.,
et al. (2006). Identiﬁcation of inﬂammatory gene modules
based on variations of human endothelial cell responses to
oxidized lipids. Proc. Natl. Acad. Sci. USA 103, 12741–12746.
14. Navab, M., Hough, G.P., Stevenson, L.W., Drinkwater, D.C.,
Laks, H., and Fogelman, A.M. (1988). Monocyte migration
into the subendothelial space of a coculture of adult human
aortic endothelial and smooth muscle cells. J. Clin. Invest.
82, 1853–1863.
15. Watson, A.D., Leitinger, N., Navab, M., Faull, K.F., Ho¨rkko¨, S.,
Witztum, J.L., Palinski, W., Schwenke, D., Salomon, R.G., Sha,
W., et al. (1997). Structural identiﬁcation by mass spectrom-
etry of oxidized phospholipids in minimally oxidized low
density lipoprotein that induce monocyte/endothelial inter-
actions and evidence for their presence in vivo. J. Biol.
Chem. 272, 13597–13607.
16. Johnson, W.E., Li, C., and Rabinovic, A. (2007). Adjusting
batch effects in microarray expression data using empirical
Bayes methods. Biostatistics 8, 118–127.
17. Bolstad, B.M., Irizarry, R.A., Astrand, M., and Speed, T.P.
(2003). A comparison of normalization methods for high
density oligonucleotide array data based on variance and
bias. Bioinformatics 19, 185–193.
18. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B.,
and Speed, T.P. (2003). Summaries of Affymetrix GeneChip
probe level data. Nucleic Acids Res. 31, e15.The Ameri19. Zhang, J., Finney, R.P., Clifford, R.J., Derr, L.K., and Buetow,
K.H. (2005). Detecting false expression signals in high-density
oligonucleotide arrays by an in silico approach. Genomics 85,
297–308.
20. Cheung, V.G., Spielman, R.S., Ewens, K.G., Weber, T.M.,
Morley, M., and Burdick, J.T. (2005). Mapping determinants
of human gene expression by regional and genome-wide asso-
ciation. Nature 437, 1365–1369.
21. Morley, M., Molony, C.M., Weber, T.M., Devlin, J.L., Ewens,
K.G., Spielman, R.S., and Cheung, V.G. (2004). Genetic anal-
ysis of genome-wide variation in human gene expression.
Nature 430, 743–747.
22. Gargalovic, P.S., Gharavi, N.M., Clark, M.J., Pagnon, J., Yang,
W.P., He, A., Truong, A., Baruch-Oren, T., Berliner, J.A., Kirch-
gessner, T.G., and Lusis, A.J. (2006). The unfolded protein
response is an important regulator of inﬂammatory genes
in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26,
2490–2496.
23. Mungrue, I.N., Pagnon, J., Kohannim, O., Gargalovic, P.S., and
Lusis, A.J. (2009). CHAC1/MGC4504 is a novel proapoptotic
component of the unfolded protein response, downstream
of the ATF4-ATF3-CHOP cascade. J. Immunol. 182, 466–476.
24. Korn, J.M., Kuruvilla, F.G., McCarroll, S.A., Wysoker, A., Nem-
esh, J., Cawley, S., Hubbell, E., Veitch, J., Collins, P.J., Darvishi,
K., et al. (2008). Integrated genotype calling and association
analysis of SNPs, common copy number polymorphisms
and rare CNVs. Nat. Genet. 40, 1253–1260.
25. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira,
M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly,
M.J., and Sham, P.C. (2007). PLINK: A tool set for whole-
genome association and population-based linkage analyses.
Am. J. Hum. Genet. 81, 559–575.
26. Hochberg, Y.B.Y. (1995). Controlling the false discovery rate: A
practical and powerful approach to multiple testing. J. R. Stat.
Soc. Series B Stat. Methodol. 57, 289–300.
27. Duggal, P., Gillanders, E.M., Holmes, T.N., and Bailey-Wilson,
J.E. (2008). Establishing an adjusted p-value threshold to
control the family-wide type 1 error in genome wide associa-
tion studies. BMC Genomics 9, 516.
28. Rockman, M.V., and Kruglyak, L. (2006). Genetics of global
gene expression. Nat. Rev. Genet. 7, 862–872.
29. Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A.S.,
Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G.B.,
Gunnarsdottir, S., et al. (2008). Genetics of gene expression
and its effect on disease. Nature 452, 423–428.
30. Go¨ring, H.H., Curran, J.E., Johnson, M.P., Dyer, T.D., Charles-
worth, J., Cole, S.A., Jowett, J.B., Abraham, L.J., Rainwater,
D.L., Comuzzie, A.G., et al. (2007). Discovery of expression
QTLs using large-scale transcriptional proﬁling in human
lymphocytes. Nat. Genet. 39, 1208–1216.
31. Veyrieras, J.B., Kudaravalli, S., Kim, S.Y., Dermitzakis, E.T.,
Gilad, Y., Stephens, M., and Pritchard, J.K. (2008). High-reso-
lutionmapping of expression-QTLs yields insight into human
gene regulation. PLoS Genet. 4, e1000214.
32. Su, N., and Kilberg, M.S. (2008). C/EBP homology protein
(CHOP) interacts with activating transcription factor 4
(ATF4) and negatively regulates the stress-dependent induc-
tion of the asparagine synthetase gene. J. Biol. Chem. 283,
35106–35117.
33. Lee, J.I., Dominy, J.E. Jr., Sikalidis, A.K., Hirschberger, L.L.,
Wang, W., and Stipanuk, M.H. (2008). HepG2/C3A cells
respond to cysteine deprivation by induction of the aminocan Journal of Human Genetics 86, 399–410, March 12, 2010 409
acid deprivation/integrated stress response pathway. Physiol.
Genomics 33, 218–229.
34. Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K., and Hayashi, H.
(2005). TRB3, a novel ER stress-inducible gene, is induced via
ATF4-CHOP pathway and is involved in cell death. EMBO J.
24, 1243–1255.
35. Oskolkova, O.V., Afonyushkin, T., Leitner, A., von Schlieffen,
E., Gargalovic, P.S., Lusis, A.J., Binder, B.R., and Bochkov, V.N.
(2008). ATF4-dependent transcription is a key mechanism in
VEGF up-regulation by oxidized phospholipids: Critical role
of oxidized sn-2 residues in activation of unfolded protein
response. Blood 112, 330–339.
36. Jousse, C., Deval, C., Maurin, A.C., Parry, L., Che´rasse, Y.,
Chaveroux, C., Leﬂoch, R., Lenormand, P., Bruhat, A., and
Fafournoux, P. (2007). TRB3 inhibits the transcriptional acti-
vation of stress-regulated genes by a negative feedback on
the ATF4 pathway. J. Biol. Chem. 282, 15851–15861.
37. Dimas, A.S., Deutsch, S., Stranger, B.E., Montgomery, S.B.,
Borel, C., Attar-Cohen, H., Ingle, C., Beazley, C., Gutierrez
Arcelus, M., Sekowska, M., et al. (2009). Common regulatory
variation impacts gene expression in a cell type-dependent
manner. Science 325, 1246–1250.
38. Dixon, A.L., Liang, L., Moffatt, M.F., Chen, W., Heath, S.,
Wong, K.C., Taylor, J., Burnett, E., Gut, I., Farrall, M., et al.
(2007). A genome-wide association study of global gene
expression. Nat. Genet. 39, 1202–1207.
39. Stranger, B.E., Nica, A.C., Forrest, M.S., Dimas, A., Bird, C.P.,
Beazley, C., Ingle, C.E., Dunning, M., Flicek, P., Koller, D.,
et al. (2007). Population genomics of human gene expression.
Nat. Genet. 39, 1217–1224.
40. Myers, A.J., Gibbs, J.R., Webster, J.A., Rohrer, K., Zhao, A.,
Marlowe, L., Kaleem, M., Leung, D., Bryden, L., Nath, P.,
et al. (2007). A survey of genetic human cortical gene expres-
sion. Nat. Genet. 39, 1494–1499.
41. Grundberg, E., Kwan, T., Ge, B., Lam, K.C., Koka, V., Kind-
mark, A., Mallmin, H., Dias, J., Verlaan, D.J., Ouimet, M.,
et al. (2009). Population genomics in a disease targeted
primary cell model. Genome Res. 19, 1942–1952.
42. Schadt, E.E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum,
P.Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C., et al.
(2008). Mapping the genetic architecture of gene expression
in human liver. PLoS Biol. 6, e107.
43. Joo, H.Y., Zhai, L., Yang, C., Nie, S., Erdjument-Bromage, H.,
Tempst, P., Chang, C., and Wang, H. (2007). Regulation of
cell cycle progression and gene expression by H2A deubiquiti-
nation. Nature 449, 1068–1072.
44. Cai, S.Y., Babbitt, R.W., and Marchesi, V.T. (1999). A mutant
deubiquitinating enzyme (Ubp-M) associates with mitotic
chromosomes and blocks cell division. Proc. Natl. Acad. Sci.
USA 96, 2828–2833.
45. Visel, A., Rubin, E.M., and Pennacchio, L.A. (2009). Genomic
views of distant-acting enhancers. Nature 461, 199–205.410 The American Journal of Human Genetics 86, 399–410, March 146. Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir,
S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A.,
Baker, A., Palsson, A., et al. (2007). A common variant on chro-
mosome 9p21 affects the risk of myocardial infarction.
Science 316, 1491–1493.
47. McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A.,
Roberts, R., Cox, D.R., Hinds, D.A., Pennacchio, L.A.,
Tybjaerg-Hansen, A., Folsom, A.R., et al. (2007). A common
allele on chromosome 9 associated with coronary heart
disease. Science 316, 1488–1491.
48. Choy, E., Yelensky, R., Bonakdar, S., Plenge, R.M., Saxena, R.,
De Jager, P.L., Shaw, S.Y., Wolﬁsh, C.S., Slavik, J.M., Cotsapas,
C., et al. (2008). Genetic analysis of human traits in vitro:
Drug response and gene expression in lymphoblastoid cell
lines. PLoS Genet. 4, e1000287.
49. Pastinen, T., Ge, B., and Hudson, T.J. (2006). Inﬂuence of
human genome polymorphism on gene expression. Hum.
Mol. Genet. 15(Spec No 1), R9–R16.
50. Leitinger, N. (2003). Oxidized phospholipids as modulators
of inﬂammation in atherosclerosis. Curr. Opin. Lipidol. 14,
421–430.
51. Drake, T.A., Hannani, K., Fei, H.H., Lavi, S., and Berliner, J.A.
(1991). Minimally oxidized low-density lipoprotein induces
tissue factor expression in cultured human endothelial cells.
Am. J. Pathol. 138, 601–607.
52. Birukova, A.A., Chatchavalvanich, S., Oskolkova, O., Boch-
kov, V.N., and Birukov, K.G. (2007). Signaling pathways
involved in OxPAPC-induced pulmonary endothelial barrier
protection. Microvasc. Res. 73, 173–181.
53. Vasques, E., Almeida, A.L., Noya, V., D’Alegria, B., Marathe, G.,
McIntyre, T.M., Tibiric¸a´, E., Bozza, P.T., Silva, A.R., and Castro-
Faria-Neto, H.C. (2006). Impairment of endothelium-depen-
dent aorta relaxation by phospholipid components of
oxidized low-density lipoprotein. Endothelium 13, 1–8.
54. Bochkov, V.N., Philippova, M., Oskolkova, O., Kadl, A., Furnk-
ranz, A., Karabeg, E., Afonyushkin, T., Gruber, F., Breuss, J.,
Minchenko, A., et al. (2006). Oxidized phospholipids stimu-
late angiogenesis via autocrine mechanisms, implicating
a novel role for lipid oxidation in the evolution of atheroscle-
rotic lesions. Circ. Res. 99, 900–908.
55. Lee, S., Li, R., Kim, B., Palvolgyi, R., Ho, T., Yang, Q.Z., Xu, J.,
Szeto, W.L., Honda, H., and Berliner, J.A. (2009). Ox-PAPC
activation of PMET system increases expression of heme oxy-
genase-1 in human aortic endothelial cell. J. Lipid Res. 50,
265–274.
56. Fahmi, S., Yang, C., Esmail, S., Hobbs, H.H., and Cohen, J.C.
(2008). Functional characterization of genetic variants in
NPC1L1 supports the sequencing extremes strategy to iden-
tify complex trait genes. Hum. Mol. Genet. 17, 2101–2107.
57. Cordell, H.J. (2009). Genome-wide association studies: Detect-
ing gene-gene interactions that underlie human diseases. Nat.
Rev. Genet. 10, 392–404.2, 2010
